Hepatocellular Carcinoma Risk Persists In HCV Patients With Another Malignancy - Gastroenterology & Endoscopy News

Click to read full article...

Gastroenterology & Endoscopy News Chicago 

Patients with hepatitis C who develop both a liver cancer and a non-liver malignancy appear to respond poorly to traditional antiviral therapies such as pegylated interferon and ribavirin, according to an analysis from a large U.S. cancer center. ...>

from HCV - Google News http://ift.tt/10dZuCB via IFTTT